Bradda Head  Lithium exceeds targets, secures US$3 million royalty and moves closer to production. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAcer Gdr Reg S Regulatory News (ACID)

Share Price Information for Acer Gdr Reg S (ACID)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.60
Bid: 0.00
Ask: 8.00
Change: 0.00 (0.00%)
Spread: 8.00 (0.00%)
Open: 7.60
High: 0.00
Low: 0.00
Prev. Close: 7.60
ACID Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

To Approve the Issuance of RSA to Key Employees

27 Mar 2014 09:38

RNS Number : 3427D
Acer Incorporated
27 March 2014
 



Subject: Acer BOD to Approve the Issuance of Restricted Stock Awards ("RSA") to Key Employees

Date of events: 2014/03/27

Contents:

1. Resolution date of the board of directors: 2014/03/27

2. Expected issue price: Granted to employees for free or by subscription at NT$10 per share tentatively. Upon the approval at the Annual Shareholders' Meeting, it is proposed that the Board of Directors is to be authorized to resolve the actual Issue Price on the Issue Date.

3. Expected total amounts (shares) of issuance: Not exceed 50,000 thousand shares

4. Determination of the terms and conditions:

(1)Vesting condition: Qualified with both of the time-based and performance-based requirements set by the issuance rules of the RSA.

(2)Type of shares: Common share of the Company.

(3)Handling of the shares that employees obtain by inheritance or fail to meet the vesting condition: The Company shall redeem or buy back at issuance price and then cancel all of those RSA that fail to meet the vesting condition.

5. Qualification requirements for employees:

For those employees who are full-time and outstanding by the Issue Date. The actual number of qualified employees shall be determined by salary, position, performance, contribution and any other factors, with consideration given to the Company's operational needs and business development strategy, pursuant to the issuance rules of the Restricted Stock Awards set by the Company within the extent permitted by law.

6. The reason why it is necessary to issue restricted stocks for employees:

To attract and retain talents, enhance employees' cohesion and sense of belonging to the Company, increase competitiveness, and foster the best interests of the Company and its shareholders.

7. Calculated expense amount:

Based on the closing price of NT$18 on March 5, 2014 for the common shares of the Company, with assumption of the shares subscripted fully at NT$10 per share, in consideration of employees' vesting period, stock price volatility and risk-free interest rate, etc., and then plugging into option pricing model, the yearly amortization of the expense amount for 2014, 2015, 2016, 2017 and 2018 is estimated to be NT$97.26M, NT$97.26M, NT$97.26M, NT$97.26M and NT$97.26M respectively.

If the Restricted Stock Awards are granted for free, the yearly amortization of the expense amount for 2014, 2015, 2016, 2017 and 2018 is estimated to be NT$180M, NT$180M, NT$180M, NT$ 180M and NT$180M respectively.

8. Dilution of EPS and other factors affecting shareholder's equity:

Based on the closing price of NT$18 on March 5, 2014 for the common shares of the Company, with assumption of the shares subscripted fully at NT$10 per share, in consideration of employees' vesting period, stock price volatility and risk-free interest rate, etc., and then plugging into option pricing model, the yearly dilution of the Company's EPS for 2014, 2015, 2016, 2017 and 2018 is approximately NT$0.035, NT$0.035, NT$0.035, NT$0.035 and NT$0.035 respectively.

If the Restricted Stock Awards are granted for free, the yearly dilution of the Company's EPS for 2014, 2015, 2016, 2017 and 2018 is approximately NT$0.065, NT$0.065 , NT$0.065, NT$0.065 and NT$0.065 respectively.

There is a limited dilution of the Company's future EPS, and there is no material impact on existing shareholders' equity.

9. Restricted rights before employees meet the vesting conditions:

With respect to the issuance of RSA, the relevant restrictions, important agreements and any other matters not set forth here shall be dealt with in accordance with the applicable laws and regulations and the issuance rules set by the Company.

10. Other important stipulations:

The RSA issued may be held in a security trust account.

11. Any other matters that need to be specified:

(1)If some revision or adjustment has to be made to due to the competent authority's instruction, amendment to the laws and regulations, financial market conditions or other objective circumstances, it is proposed that the Annual Shareholders' Meeting authorizes the Board of Directors with full power and authority to handle all the issues regarding the issuance of Restricted Stock Awards.

(2)This 50,000 thousand shares account for 1.78 % of the total number of the Company's issued shares of 2,806,107,828 shares after stock cancellation of the First Buyback in Year 2011 from the date of May 26, 2014.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFVAVRIDFIS
Date   Source Headline
28th Jun 20243:29 pmRNSTo announce the Company's information
11th Jun 20248:45 amRNSUn-Audited Monthly Sales Ended May 31, 2024
4th Jun 202410:23 amRNSTo announce the Company's information
31st May 202410:53 amRNSTo announce the Company's information
10th May 202411:08 amRNSTo announce the Company's information
9th May 202410:59 amRNSTo announce the Company's information
18th Apr 202410:15 amRNSTo announce the Company's information
11th Apr 202410:23 amRNSTo announce the Company's information
10th Apr 202410:16 amRNSUn-Audited Monthly Sales Ended Mar. 31, 2024
2nd Apr 20247:00 amRNSTo Announce the Company's Infomation
14th Mar 202410:01 amRNSTo announce the Company's information
7th Mar 20249:45 amRNSUn-Audited Monthly Sales Ended Feb. 29, 2024
26th Feb 20249:38 amRNSTo announce the Company's information
19th Feb 20249:11 amRNSTo announce the Company's information
7th Feb 20248:03 amRNSUn-Audited Monthly Sales Ended Jan. 31, 2024
17th Jan 202410:05 amRNSTo announce the Company's information
8th Jan 20249:24 amRNSUn-Audited Monthly Sales Ended Dec. 31, 2023
27th Dec 20237:00 amRNSTo announce the Company's information
11th Dec 20239:44 amRNSUn-Audited Monthly Sales Ended Nov. 30, 2023
9th Nov 20239:21 amRNSUn-Audited Monthly Sales Ended Oct. 31, 2023
2nd Nov 20239:15 amRNSTo announce the Company's information
24th Oct 20232:34 pmRNSTo announce the Company's information
16th Oct 20237:24 amRNSTo announce the Company's information
11th Oct 202310:36 amRNSUn-Audited Monthly Sales Ended Sep. 30, 2023
26th Sep 202310:07 amRNSTo announce the Company's information
8th Sep 202310:20 amRNSTo announce the Company's sales and information
5th Sep 20237:10 amRNSTo announce the Company's information
23rd Aug 202310:17 amRNSTo announce the Company's information
9th Aug 202310:13 amRNSUn-Audited Monthly Sales Ended July 31, 2023
8th Aug 202312:16 pmRNSTo announce the Company's information
3rd Aug 20231:09 pmRNSTo announce the Company's information
10th Jul 20237:00 amRNSUn-Audited Monthly Sales Ended June 30, 2023
29th Jun 202310:54 amRNSTo announce the Company's information
8th Jun 202310:17 amRNSUn-Audited Monthly Sales Ended May 31, 2023
7th Jun 20237:00 amRNSTo announce the Company's information
9th May 202310:35 amRNSTo announce the Company's info and Monthly Revenue
4th May 202311:14 amRNSTo announce the Company's information
24th Apr 202310:32 amRNSTo announce the Company's information
11th Apr 202311:05 amRNSTo announce the Company's info and Monthly Revenue
11th Apr 20237:00 amRNSTo announce the Company's information
31st Mar 202310:13 amRNSTo announce the Company's information
16th Mar 202310:24 amRNSTo announce the Company's information
10th Mar 20239:06 amRNSUn-Audited Monthly Sales Ended Feb. 28, 2023
8th Mar 20232:23 pmRNSTo announce the Company's information
2nd Mar 20239:05 amRNSTo announce the Company's information
10th Feb 20239:05 amRNSUn-Audited Monthly Sales Ended Jan. 31, 2023
9th Jan 202310:07 amRNSUn-Audited Monthly Sales Ended Dec. 31, 2022
4th Jan 20239:56 amRNSTo announce the Company's information
16th Dec 20229:12 amRNSTo announce the Company's information
9th Dec 20229:06 amRNSUn-Audited Monthly Sales Ended Nov. 30, 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.